United States v. AZ Diabetic Supply, Inc.

CourtDistrict Court, E.D. Virginia
DecidedMay 25, 2023
Docket1:22-cv-00965
StatusUnknown

This text of United States v. AZ Diabetic Supply, Inc. (United States v. AZ Diabetic Supply, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. AZ Diabetic Supply, Inc., (E.D. Va. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF VIRGINIA Alexandria Division

UNITED STATES OF AMERICA, ) Plaintiff, v. 1:22-cv-965 (LMB/IDD) AZ DIABETIC SUPPLY, INC., et al., Defendants. MEMORANDUM OPINION Before the Court is the plaintiff United States of America’s (“plaintiff’ or “United States”) Motion for Default Judgment (“Motion”) as to defendants AZ Diabetic Supply, Inc. (“AZ Diabetic”) and Hisham Zaghal (“Zaghal”). Since the United States filed its Motion, counsel has entered an appearance on behalf of defendant Zaghal, and Zaghal has filed an Answer to the Complaint. [Dkt. Nos. 29, 31]. Accordingly, the Court will deny the Motion as to defendant Zaghal; however, defendant AZ Diabetic has not retained counsel, and it has neither filed an answer nor a responsive pleading nor requested additional time to retain counsel or respond to the Complaint. For the reasons that follow, the plaintiff's Motion as to defendant AZ Diabetic will be granted. I. BACKGROUND A. Statutory Background This civil action is brought under the False Claims Act, 31 U.S.C. §§ 3729-3733, based on alleged violations of the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b, through a fraud perpetrated on the Medicare program by AZ Diabetic. Medicare is a federal healthcare program that provides benefits to individuals age 65 or older and individuals under 65 with disabilities. It

includes Medicare Part B, which authorizes federal funds to be used to pay for medical services, including certain medically-necessary orthotic braces and equipment. A beneficiary must have a medical need for such devices and have secured either a prescription or certification of medical necessity from a licensed practitioner to receive these devices, which are often referred to as durable medical equipment (DME). Medicare-enrolled DME providers, such as defendant, are required to certify that they will comply with all Medicare laws and regulations, including the Anti-Kickback statute, which prohibits any provider from: knowingly and willfully offer[ing] or pay[ing] any remuneration (including any kickback, bribe, or rebate) directly or indirectly, overtly or covertly, in cash or in kind to any person to induce such person— (A) to refer an individual to a person for the furnishing or arranging for the furnishing of any item or service for which payment may be made in whole or in part under a Federal health care program, or (B) to purchase, lease, order, or arrange for or recommend purchasing, leasing, or ordering any good, facility, service, or item for which payment may be made in whole or in part under a Federal health care program, 42 U.S.C. § 1320a-7b(b)(2). The statute further states that claim that includes items or services resulting from a violation of this section constitutes a false or fraudulent claim for purposes of [the False Claims Act].” Id. at § 1320a-7b(g). The False Claims Act states that any individual who (A) knowingly presents, or causes to be presented, a false or fraudulent claim for payment or approval; (B) knowingly makes, uses, or causes to be made or used, a false record or statement material to a false or fraudulent claim... is liable to the United States Government for a civil penalty of not less than $5,000 and not more than $10,000, as adjusted by the Federal Civil Penalties Inflation Adjustment Act of 1990 (28 U.S.C. 2461 note; Public Law 104-4101), plus 3 times the amount of damages which the Government sustains because of the act of that person.

31 U.S.C. § 3729(a)(1). Under the False Claims Act, the terms “knowing” and “knowingly”

(A) mean that a person, with respect to information— (i) has actual knowledge of the information; (ii) acts in deliberate ignorance of the truth or falsity of the information; or (iii) acts in reckless disregard of the truth or falsity of the information; and (B) require no proof of specific intent to defraud. Id. at § 3729(b)(1). B. Factual Background The uncontested well-pleaded facts alleged in the Complaint establish the following. AZ Diabetic, a Medicare-enrolled provider since 2002, is a for-profit Virginia corporation that supplied DME braces to patients. [Dkt. No. 1] at J] 6, 18, 19. Since 2006, it has been owned and operated by Zaghal. Id. at ] 7. From January 2016 through December 2021, Medicare paid AZ Diabetic an estimated $1,297,347.08 to reimburse claims for DME that AZ Diabetic supplied to Medicare-covered patients. Id. at 9 19. AZ Diabetic received at least $612,329.16 in reimbursements based on prescriptions purchased from two companies: RealTime Consulting & Marketing, Inc., Quality Rx Solutions (“RealTime”) and LPI Media Group (“LPI”). Id, at J 21. RealTime was owned and operated by Nathan LaParl (“LaParl’’) from January 2014 through July 2019, and served as an intermediary call center that connected Medicare patients and DME suppliers, such as AZ Diabetic. Id. at ¢23. RealTime would purchase Medicare beneficiaries’ contact information from companies that ran targeted advertisements to Medicare recipients, and then have its call center employees use a RealTime-produced script to call Medicare beneficiaries to inquire whether they were interested in receiving DME “at little to no

cost.” Id. at | 24. Ifa beneficiary expressed interest, RealTime would collect the beneficiary’s personal information and contact his or her primary care physician to request a prescription for DME. Id. After receiving DME prescriptions, RealTime sold the prescriptions to DME suppliers, including AZ Diabetic. Id. at 25. On January 7, 2020, LaParl pleaded guilty to receiving kickbacks in connection with a federal healthcare program, in violation of the Anti- Kickback Statute and HIPAA, 42 U.S.C. § 1320d-6. Id. at 7 33. AZ Diabetic “through its owner Zaghal” paid a fee to RealTime for each prescription it purchased. Id. at | 26. This fee fluctuated based on the price of the DME brace prescribed, with more expensive braces earning RealTime a higher fee. Id. RealTime’s owner, LaParl, verified to plaintiff that Zaghal understood AZ Diabetic to be purchasing DME prescriptions themselves, rather than beneficiary contact information or marketing leads. Id. LaParl guaranteed that Medicare would reimburse AZ Diabetic for the prescriptions it purchased from RealTime. Id. at { 29. When Medicare denied reimbursement for certain braces, because, for example, the “same or similar” device had been provided to the beneficiary within a given period, LaParl provided substitute prescriptions to AZ Diabetic at Zaghal’s request. Id. AZ Diabetic purchased at least 347 prescriptions from RealTime between August 2016 and April 2017, and submitted claims based on these prescriptions to Medicare, which paid defendant a total of $234,978.93. Id. at 22, 30. AZ Diabetic also purchased DME prescriptions from LPI, a company owned and operated by Steven Churchill (“Churchill”), which purchased qualified leads from RealTime for $150 per lead. Id. at J 35-36. Using these leads, LPI paid telemedicine doctors to write DME prescriptions and sold the prescriptions and patients’ personal and medical data to DME suppliers, including AZ Diabetic. Id. On November 19, 2020, Churchill was indicted for

receiving and soliciting kickbacks in connection with a federal healthcare program, in violation of the Anti-Kickback Statute. Id. at ] 42.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
United States v. AZ Diabetic Supply, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-az-diabetic-supply-inc-vaed-2023.